Literature DB >> 10527463

Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells.

D K Kim1, Y Fujiki, T Fukushima, H Ema, A Shibuya, H Nakauchi.   

Abstract

Although the hematopoietic activities of human CD34+ bone marrow (BM) and cord blood (CB) cells have been well characterized, the phenotype of nonobese-diabetic severe combined immunodeficient (NOD/SCID) mice repopulating cells (SRCs) in CB and BM has not yet been fully examined. To address this issue, various hematopoietic activities were compared in terms of total and CD34+ CB and BM cells. Clonal culture of fluorescence-activated cell sorter (FACS) CD34+ CB and BM cells revealed a higher incidence of colony-forming cells with greater proliferation capacity in CB over BM CD34+ cells. CB CD34+ cells also demonstrated higher secondary plating efficiency over BM cells. In addition, we demonstrated that mice transplanted with CB mononuclear cells (MNCs) showed significantly higher levels of chimerism than those transplanted with BM MNCs. However, recipients of FACS-sorted CD34+ CB cells showed significantly lower levels of chimerism than those that received total CB MNCs, suggesting a role of facilitating cells in the CD34- cell population. To further analyze the role of CD34- cells, the NOD/SCID repopulating ability of FACS-sorted CB CD34-c-kit+Lin- and CD34-c-kit-Lin- cells were examined. However, SRCs were not detected in those cells. Taken together, these data suggest that CB is a better source of hematopoietic stem cells and that there are cells in the CD34- fraction that facilitate repopulation of hematopoiesis in the NOD/SCID environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527463     DOI: 10.1002/stem.170286

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  16 in total

1.  Immunophenotyping of hematopoietic progenitor cells: Comparison between cord blood and adult mobilized blood grafts.

Authors:  Nesrine Ben Azouna; Lamia Berraeis; Zohra Regaya; Faouzi Jenhani
Journal:  World J Stem Cells       Date:  2011-11-26       Impact factor: 5.326

Review 2.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 3.  Private cord blood banking: current use and clinical future.

Authors:  Peter Hollands; Catherina McCauley
Journal:  Stem Cell Rev Rep       Date:  2009-07-15       Impact factor: 5.739

4.  Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro.

Authors:  Xiao-Peng Tang; Min Zhang; Xu Yang; Li-Min Chen; Yang Zeng
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

5.  Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.

Authors:  Tâm D Quách; Thomas J Hopkins; Nichol E Holodick; Raja Vuyyuru; Tim Manser; Ruthee-Lu Bayer; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

Review 6.  Engineering cord blood to improve engraftment after cord blood transplant.

Authors:  Rohtesh S Mehta; Hema Dave; Catherine M Bollard; Elizabeth J Shpall
Journal:  Stem Cell Investig       Date:  2017-05-25

7.  Clinical and experimental study on therapeutic effect of umbilical cord blood transplantation on severe viral hepatitis.

Authors:  Xiao-Peng Tang; Xu Yang; Hui Tan; Yi-Ling Ding; Min Zhang; Wen-Long Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 8.  Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications.

Authors:  Sabine Hombach-Klonisch; Soumya Panigrahi; Iran Rashedi; Anja Seifert; Esteban Alberti; Paola Pocar; Maciej Kurpisz; Klaus Schulze-Osthoff; Andrzej Mackiewicz; Marek Los
Journal:  J Mol Med (Berl)       Date:  2008-07-16       Impact factor: 4.599

Review 9.  Establishing humanized mice using stem cells: maximizing the potential.

Authors:  D Bernard; M Peakman; A C Hayday
Journal:  Clin Exp Immunol       Date:  2008-04-24       Impact factor: 4.330

10.  Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin.

Authors:  Lisa A Kohn; Qian-Lin Hao; Rajkumar Sasidharan; Chintan Parekh; Shundi Ge; Yuhua Zhu; Hanna K A Mikkola; Gay M Crooks
Journal:  Nat Immunol       Date:  2012-09-02       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.